Dengue fever is a major public health problem in the world, because it is especially endemic in the tropical and subtropical areas. Arbovirus infection is less well documented in African countries. We aimed to assess the distribution of patients in the dengue epidemic and the seroprevalence of different serotypes of the circulating dengue virus. A retrospective study included analyses of human blood samples sent to the National Reference Laboratory for diagnosis during dengue infection outbreak. Samples were screened by IgM capture ELISA (MAC-ELISA) or by RT-PCR. Of the 2,849 serum samples from suspected dengue cases, 2,297 (80.6%) were from Abidjan. The seroprevalence of dengue was (15.1%) during this epidemic. The seroprevalence of dengue virus serotypes in cocirculation was predominated by DENV-2 with 189 cases (6.6%), followed by DENV-3 77 cases (2.7%), and DENV-1 14 cases (0.5%). The seroprevalence in children was 8.7% compared to 19.0% in adults. The age group of 16 to less than 45 years accounted for 54.0% of total positive cases. In addition, positive peak was observed in July (28.3%) and Abidjan East was the most affected locality. The increasing trend of serotypes of the dengue virus cocirculation suggests that Abidjan is becoming a hyperendemic state from an endemic one.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright 漏 2025 scite LLC. All rights reserved.
Made with 馃挋 for researchers
Part of the Research Solutions Family.